Antiretroviral Therapy Archives | Themedicinevilla.com

Showing 1–12 of 29 results

Abamune 300 mg (Abacavir)
0 out of 5
Price range: $70 through $185
Abamune 300 mg (Abacavir Tablets) contains abacavir, a nucleoside reverse transcriptase inhibitor used to suppress HIV‑1 replication. Typically used in combination with other ARVs, Abamune helps lower viral load, maintain immune health, and slow disease progression. Administered once or twice daily under medical supervision in adult patients.

Select options This product has multiple variants. The options may be chosen on the product page
Abamune‑L (Abacavir + Lamivudine)
0 out of 5
Price range: $150 through $455
Abamune‑L (Abacavir + Lamivudine Tablets) is a fixed-dose combination tablet containing two nucleoside reverse transcriptase inhibitors (abacavir and lamivudine) for HIV‑1 treatment. This dual-NRTI regimen reduces viral replication and supports immune health. Designed for once‑daily use (or twice daily if prescribed), Abamune‑L simplifies therapy under clinical guidance.

Select options This product has multiple variants. The options may be chosen on the product page
Abec‑L (Abacavir + Lamivudine)
0 out of 5
Price range: $140 through $410
Abec‑L (Abacavir + Lamivudine Tablets) is a single daily tablet combining two NRTIs: abacavir and lamivudine. This fixed-dose regimen helps suppress HIV‑1 reverse transcriptase activity, reduce viral replication, and support immune system recovery, while simplifying treatment under physician guidance.

Select options This product has multiple variants. The options may be chosen on the product page
Atavir 300 mg (Atazanavir)
0 out of 5
Price range: $145 through $425
Atavir 300 mg (Atazanavir Tablets) contain atazanavir, an HIV‑1 protease inhibitor used to suppress viral replication in antiretroviral therapy regimens. It’s administered once daily under medical supervision and may be combined with a pharmacoenhancer like ritonavir or cobicistat. Atavir helps maintain immune function and reduce viral load with convenient oral dosing.

Select options This product has multiple variants. The options may be chosen on the product page
Atazor‑R (Atazanavir 300 mg + Ritonavir 100 mg)
0 out of 5
Price range: $150 through $450
Atazor‑R (Atazanavir 300 mg + Ritonavir 100 mg Tablets) combines atazanavir and ritonavir in a fixed-dose form. Ritonavir acts as a pharmacokinetic booster, enhancing atazanavir absorption and plasma levels, which helps simplify once-daily dosing. It offers strong HIV‑1 protease inhibition and immune support under medical supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Axentri 150 mg (Maraviroc)
0 out of 5
Price range: $680 through $2,000
Axentri 150 mg (Maraviroc Tablets) contains maraviroc, a CCR5 receptor antagonist used in HIV‑1 treatment. It works by blocking viral entry into target CD4 cells that use the CCR5 co-receptor. Prescribed for patients with CCR5‑tropic HIV‑1, Axentri is typically used alongside other ARVs to maintain viral suppression and immune restoration under specialist supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Daruvir 600 mg (Darunavir)
0 out of 5
Price range: $490 through $1,470
Daruvir 600 mg (Darunavir Tablets) contains darunavir, a potent HIV‑1 protease inhibitor used to reduce viral replication in antiretroviral regimens. Typically co-administered with a booster (ritonavir or cobicistat) to maximize effectiveness, Daruvir supports improved immune outcomes and viral suppression with once-daily oral dosing under clinical supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Dinex EC (Didanosine)
0 out of 5
Price range: $90 through $285
Dinex‑EC (Didanosine EC Tablets) contains didanosine, a nucleoside reverse transcriptase inhibitor (NRTI) used in HIV‑1 treatment regimens. The enteric-coated formulation helps minimize gastrointestinal side effects and improve tolerability. Dinex‑EC suppresses viral replication and supports immune recovery when used in combination therapy under medical supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Duovir 150 mg/300 mg (Lamivudine + Zidovudine)
0 out of 5
Price range: $120 through $350
Duovir 150 mg/300 mg (Lamivudine + Zidovudine Tablets) is a fixed-dose combination that pairs lamivudine and zidovudine—two nucleoside reverse transcriptase inhibitors (NRTIs)—for HIV‑1 treatment. Designed for use in antiretroviral regimens, Duovir helps reduce viral replication and maintain immune health. Its once- or twice-daily oral administration simplifies therapy under clinician supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Duovir‑E Kit (Lamivudine 150 mg + Zidovudine 300 mg + Efavirenz 600 mg)
0 out of 5
Price range: $66 through $146
Duovir‑E Kit (Lamivudine 150 mg + Zidovudine 300 mg + Efavirenz 600 mg Tablets) is a fixed-dose combination regimen used in HIV‑1 treatment. It merges two nucleoside reverse transcriptase inhibitors (lamivudine and zidovudine) with a non-nucleoside reverse transcriptase inhibitor (efavirenz) for potent viral suppression, immune restoration, and simplified daily dosing under clinical supervision.

Select options This product has multiple variants. The options may be chosen on the product page
Duovir‑N 150 mg/200 mg/300 mg
0 out of 5
Price range: $75 through $200
Duovir‑N 150 mg/200 mg/300 mg (Lamivudine + Zidovudine + Nevirapine Tablets) is a fixed‑dose combination tablet used in HIV‑1 treatment. This regimen combines lamivudine and zidovudine, two NRTIs, with nevirapine, an NNRTI, to reduce viral replication and restore immune function. Administered once or twice daily under clinical supervision, it supports adherence and simplifies long-term antiretroviral therapy.

Select options This product has multiple variants. The options may be chosen on the product page
Efavir
0 out of 5
Price range: $90 through $295
Efavir (Efavirenz 600 mg Tablets) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy to suppress HIV‑1 replication. Known for its once-daily dosing and established efficacy, Efavirenz helps reduce viral load and supports immune recovery as part of a multidrug regimen under medical supervision.

Select options This product has multiple variants. The options may be chosen on the product page